A New Era for Kinvent

As a company dedicated to the development of health sectors in France, Eurazeo is taking a minority stake, alongside Athanase Kollias, founding chairman, and existing minority shareholders including Unifund, Sofilaro, BADGE, and Rapha\xebl Varane among others.Reflecting on the new partnership, Athanase Kollias, President, and founder of Kinvent said, Our teams are delighted to welcome Eurazeo, a leading investment player, so we can build towards the goal of being the world leader in connected solutions for physiotherapy and sports practitioners together. We are at a structuring stage in our history, in a rapidly expanding market, and have been convinced by the Nov Sant\xe9 teams ability to accompany Kinvents development, its knowledge of the Health market, and its internal expertise,To achieve our ambitions, we will rely on the health expertise and experience of the Nov Sant\xe9 team in structuring a rapidly growing company and executing a broad commercial development plan. This investment aligns perfectly with Nov Sant\xe9s strategy to participate in the digitization of a healthcare profession and accelerate the transformation of French and European SMEs,At Kinvent, our mission is to make the most objective, results driven physiotherapy not only possible but accessible to physiotherapy and sports medicine experts everywhere. We look forward to leveraging this spectacular investment along with the invaluable expertise of our new partners Eurazeo to continue making great strides in physiotherapy innovation as well as maximizing our potential to touch the lives of countless more patients. To learn more, read the press release for this monumental moment in our companys history here.